We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-8.48%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$3.62B
AUM Growth
+$1.57B
Cap. Flow
+$1.57B
Cap. Flow %
43.42%
Top 10 Hldgs %
77.72%
Holding
160
New
40
Increased
46
Reduced
26
Closed
16

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$42.5M
2
AAPL icon
Apple
AAPL
+$24.5M
3
SMTC icon
Semtech
SMTC
+$18.5M
4
HUBS icon
HubSpot
HUBS
+$18.2M
5
HLIT icon
Harmonic Inc
HLIT
+$15.7M

Top Sells

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$32.5M
2
LIVN icon
LivaNova
LIVN
+$27.9M
3
PRMW
Primo Water Corporation
PRMW
+$22.9M
4
TKO icon
TKO Group
TKO
+$13.9M
5
QDEL icon
QuidelOrtho
QDEL
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 10.3%
2 Healthcare 6.64%
3 Consumer Discretionary 5.86%
4 Communication Services 3.86%
5 Industrials 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIVN icon
101
FIVE9
FIVN
$1.91B
$1.61M 0.04%
+36,413
New +$1.89M
ENFN
102
DELISTED
Enfusion, Inc.
ENFN
$1.56M 0.04%
183,174
-70,738
-28% -$647K
BLMN icon
103
Bloomin' Brands
BLMN
$717M
$1.54M 0.04%
80,320
– –
HAS icon
104
Hasbro
HAS
$12.6B
$1.51M 0.04%
25,792
– –
DOCU
105
DocuSign
DOCU
$10.3B
$1.5M 0.04%
+28,067
New +$1.58M
VTRS icon
106
Viatris
VTRS
$20.5B
$1.4M 0.04%
131,941
– –
DBD icon
107
Diebold Nixdorf
DBD
$3.17B
$1.38M 0.04%
35,850
-295,432
-89% -$11.3M
CHRS icon
108
Coherus Oncology
CHRS
$225M
$1.36M 0.04%
784,449
– –
RARE icon
109
Ultragenyx Pharmaceutical
RARE
$2.67B
$1.35M 0.04%
+32,961
New +$1.41M
EB
110
DELISTED
Eventbrite
EB
$1.33M 0.04%
274,958
– –
PD icon
111
PagerDuty
PD
$750M
$1.32M 0.04%
+57,680
New +$1.2M
OPTU
112
Optimum Communications Inc
OPTU
$307M
$1.3M 0.04%
636,406
– –
NUVB icon
113
Nuvation Bio
NUVB
$2.29B
$1.28M 0.04%
437,237
– –
ILMN icon
114
Illumina
ILMN
$28.6B
$1.18M 0.03%
+11,290
New +$1.27M
CSTM icon
115
Constellium
CSTM
$3.95B
$1.09M 0.03%
+57,853
New +$1.2M
TXMD icon
116
TherapeuticsMD
TXMD
$24.2M
$1.02M 0.03%
636,622
+101,282
+19% +$204K
MAGN
117
Magnera Corp
MAGN
$488M
$980K 0.03%
54,210
+10,071
+23% +$217K
IAS
118
DELISTED
Integral Ad Science
IAS
$916K 0.03%
+94,223
New +$902K
FRSH icon
119
Freshworks
FRSH
$3.02B
$916K 0.03%
+72,149
New +$1.08M
EHAB
120
DELISTED
Enhabit
EHAB
$873K 0.02%
97,923
-100
-0.1% -$956
SNDX icon
121
Syndax Pharmaceuticals
SNDX
$1.85B
$866K 0.02%
+42,195
New +$883K
LNSR icon
122
LENSAR
LNSR
$67.5M
$779K 0.02%
173,004
– –
NABL icon
123
N-able
NABL
$831M
$759K 0.02%
+49,845
New +$656K
OLO
124
DELISTED
Olo Inc
OLO
$750K 0.02%
169,737
+129,874
+326% +$615K
CMP icon
125
Compass Minerals
CMP
$1.23B
$666K 0.02%
64,429
– –
3 4
5
6 7

Similar funds

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Clearline Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Clearline Capital held 160 positions worth $3.62B, up 77% from $2.05B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Clearline Capital deployed $1.57B of net new capital in Q2 2024, opening 40 new positions and adding to 46 existing holdings. Its largest new stake was HubSpot: 29,742 shares worth $17.5M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Primo Water Corporation, an estimated $22.9M trimmed.

  • Clearline Capital's largest Q2 2024 buy was HubSpot: 29,742 shares worth $17.5M.
  • Clearline Capital added most to Teladoc Health in Q2 2024, an estimated $42.5M increase.
  • Clearline Capital's biggest Q2 2024 reduction was Primo Water Corporation, cutting an estimated $22.9M.
  • Clearline Capital fully exited Fidelity National Information Services in Q2 2024, selling an estimated $32.5M.
  • Clearline Capital's ten largest holdings make up 78% of its $3.62B portfolio in Q2 2024.
  • Clearline Capital opened 40 new positions and closed 16 in Q2 2024.
  • Clearline Capital's portfolio value rose 77% quarter-over-quarter to $3.62B.

Based on Clearline Capital's 13F filing for Q2 2024, filed 15 Aug 2024.